Search

Your search keyword '"Christa Nagel"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Christa Nagel" Remove constraint Author: "Christa Nagel" Topic medicine.disease Remove constraint Topic: medicine.disease
32 results on '"Christa Nagel"'

Search Results

1. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020

2. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

3. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

4. Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration

5. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

6. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator

7. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence

8. Dosimetric Analysis Using the Venezia Applicator, and Comparison with the Split Ring Applicator, in Combined Intracavitary/Interstitial High Dose Rate Brachytherapy for Cervix Cancer

9. Survival Outcomes of Clinical Trials in Patients With Recurrent Cervical Cancer

10. A multi-institutional cohort study of adjuvant therapy in stage I–II uterine carcinosarcoma

11. The wnt/β-catenin-specific inhibitor, ICG-001, proves effective for the treatment of high-grade serous ovarian cancer in murine models through the targeting of cancer initiating cells

13. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study

14. Abstract A85: Receipt of adjuvant endometrial carcinoma treatment according to race: An NRG Oncology/Gynecologic Oncology Group 210 Study

15. Identifying susceptibilities and pharmacodynamic biomarkers for mirvetuximab soravtansine in high-grade ovarian and endometrial cancer

16. A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression

17. 3T MRI-Guided High Dose Rate Adaptive Brachytherapy for the Treatment of Cervical Cancer

18. Abstract C44: Endometrial carcinoma recurrence in black and white women in the NRG Oncology/Gynecologic Oncology Group 210 trial

19. PRO: Secondary Surgical Debulking is an Acceptable Option in Patients With Recurrent Platinum-Sensitive Ovarian Cancer

20. Adnexal masses requiring surgical intervention in women with advanced cervical cancer

21. Adjuvant External Radiation is Essential in the Management of Pelvis-Limited Stage III Endometrial Carcinoma

22. The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer

23. Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes

24. Outcomes of locally advanced cervical cancer in an underserved indigent US population

25. Clinical course of ovarian cancer after two salvage regimens

28. Effect of BMI on progesterone therapy for endometrial cancer

29. Abstract 2904: Lyophilized black raspberry extract modulates interleukin 8 expression in human cervical cancer: An insight into phytochemical-based chemoprevention?

30. Clinical and pathologic correlation of p73 expression in surgically staged endometrial cancer

31. Improved outcomes in advanced stage uterine carcinosarcoma (mixed mullerian tumor [MMT])

32. Prognostic Significance of Nodal Location in Stage IIIC Endometrial Carcinoma: Implications for Optimal Adjuvant Therapy

Catalog

Books, media, physical & digital resources